Page last updated: 2024-10-30

mebeverine and Bladder Cancer

mebeverine has been researched along with Bladder Cancer in 2 studies

mebeverine: RN given refers to parent cpd; structure

Research Excerpts

ExcerptRelevanceReference
"The meanĀ±SD 3-month urinary domain of Bladder Cancer Index was 67."3.01A Randomized Trial to Examine the Utility of Mebeverine on the Early Return of Continence Following Orthotopic Bladder Substitution. ( Abdellutif, MM; Abol-Enein, H; El-Hefnawy, AS; Hashem, A; Laymon, M; Mosbah, A; Ramez, M; Taha, MT, 2021)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Hashem, A2
Abol-Enein, H2
Laymon, M2
Abdellutif, MM2
Ramez, M1
Taha, MT1
El-Hefnawy, AS1
Mosbah, A2
Abdullateef, M1
Abdelhamid, A1

Trials

2 trials available for mebeverine and Bladder Cancer

ArticleYear
A Randomized Trial to Examine the Utility of Mebeverine on the Early Return of Continence Following Orthotopic Bladder Substitution.
    The Journal of urology, 2021, Volume: 205, Issue:5

    Topics: Aged; Cystectomy; Double-Blind Method; Humans; Male; Middle Aged; Phenethylamines; Postoperative Com

2021
Clinical efficacy of mebeverine for persistent nocturnal enuresis after orthotopic W-neobladder.
    BJU international, 2022, Volume: 129, Issue:3

    Topics: Adult; Cystectomy; Female; Humans; Male; Nocturnal Enuresis; Phenethylamines; Quality of Life; Treat

2022